Fairchem Organics Balance Sheet Health
Financial Health criteria checks 5/6
Fairchem Organics has a total shareholder equity of ₹2.7B and total debt of ₹341.6M, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are ₹3.3B and ₹650.2M respectively. Fairchem Organics's EBIT is ₹586.4M making its interest coverage ratio 11.9. It has cash and short-term investments of ₹687.0K.
Key information
12.8%
Debt to equity ratio
₹341.61m
Debt
Interest coverage ratio | 11.9x |
Cash | ₹687.00k |
Equity | ₹2.66b |
Total liabilities | ₹650.17m |
Total assets | ₹3.31b |
Recent financial health updates
Recent updates
Fairchem Organics (NSE:FAIRCHEMOR) Has A Pretty Healthy Balance Sheet
Mar 13Fairchem Organics' (NSE:FAIRCHEMOR) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 29Fairchem Organics (NSE:FAIRCHEMOR) Is Paying Out Less In Dividends Than Last Year
Jul 15Fairchem Organics' (NSE:FAIRCHEMOR) Dividend Will Be Reduced To ₹7.50
Jun 02Under The Bonnet, Fairchem Organics' (NSE:FAIRCHEMOR) Returns Look Impressive
Apr 26Fairchem Organics Limited's (NSE:FAIRCHEMOR) Popularity With Investors Is Under Threat From Overpricing
Feb 08Fairchem Organics (NSE:FAIRCHEMOR) Is Very Good At Capital Allocation
Nov 01We Think You Should Be Aware Of Some Concerning Factors In Fairchem Organics' (NSE:FAIRCHEMOR) Earnings
May 25Investors Shouldn't Overlook Fairchem Organics' (NSE:FAIRCHEMOR) Impressive Returns On Capital
Jan 10Financial Position Analysis
Short Term Liabilities: FAIRCHEMOR's short term assets (₹1.3B) exceed its short term liabilities (₹479.2M).
Long Term Liabilities: FAIRCHEMOR's short term assets (₹1.3B) exceed its long term liabilities (₹171.0M).
Debt to Equity History and Analysis
Debt Level: FAIRCHEMOR's net debt to equity ratio (12.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if FAIRCHEMOR's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: FAIRCHEMOR's debt is well covered by operating cash flow (52.1%).
Interest Coverage: FAIRCHEMOR's interest payments on its debt are well covered by EBIT (11.9x coverage).